PHI University Psychiatric Clinic - Skopje

Global Perspectives on Medical Cannabis Products: Knowledge, Attitudes, Clinical Use, and Safety Perceptions Among Healthcare Professionals and Patients

Introduction. Medical cannabis and cannabinoid-based medicinal products (CBMPs) are increasingly considered in managing chronic pain, neurological disorders, epilepsy, oncology-related symptoms, and palliative care. However, their safe clinical integration is influenced by health...

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

BackgroundPatients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with minimal bleeding risk. MethodsIn this phase 3, randomized, placebo-con...